MedPath

FORMULA30A LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

Not Applicable
Completed
Conditions
Health, Subjective
Inflammatory Response
Side Effect
Adverse Effect
First Posted Date
2023-02-24
Last Posted Date
2025-02-27
Lead Sponsor
Formula30A LLC
Target Recruit Count
69
Registration Number
NCT05743985
Locations
🇺🇸

Institute for Hormonal Balance, Arlington, Texas, United States

🇺🇸

NP Care Clinic, Denton, Texas, United States

🇺🇸

Infectious Disease Specialists, Edinburg, Texas, United States

and more 3 locations

Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD)

Completed
Conditions
Generalized Anxiety Disorder
First Posted Date
2021-08-27
Last Posted Date
2021-08-27
Lead Sponsor
Formula30A LLC
Target Recruit Count
30
Registration Number
NCT05023759
Locations
🇺🇸

NP Care Clinic, Denton, Texas, United States

🇺🇸

Dr. Michael Jelinek, MD, Edinburg, Texas, United States

🇺🇸

Modern Medicine, Forney, Texas, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.